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SUMMARY – Detecting predictors of poor outcome is crucial for understanding the underlying 
pathophysiology of heart failure (HF) and thus creating new therapeutic concepts. It is well estab-
lished that low serum lipid levels are associated with unfavorable outcomes in HF patients. Several 
studies examined the association between serum lipids and established predictors of mortality in HF 
patients. The aim of the present study was to examine the association of serum lipid and chloride 
concentrations, as well as their impact on survival in acute heart failure (AHF). The present study was 
performed as a prospective, single-centre, observational research. The study included 152 patients with 
AHF. Spearman’s correlation coefficient revealed a significant positive correlation of serum chloride 
levels with serum levels of total cholesterol (ρ 0.221, p=0.006), low-density lipoprotein cholesterol 
(LDL-c) (ρ 0.187, p=0.015) and high-density lipoprotein-cholesterol (HDL-c) (ρ 0.169, p=0.038). 
Binary logistic regression revealed a significant association of chloride, total cholesterol and LDL-c 
serum levels measured at admission with hospital survival (OR 1.077, CI 1.01-1.154, p=0.034), (OR 
1.731, CI 1.090-2.748, p=0.020) and (OR 1.839, CI 1.033-3.274, p=0.038), respectively, as well as 
with 3-month survival (OR 1.065, CI 1.002-1.131, p=0.042), (OR 1.625, CI 1.147-2.303, p=0.006) 
and (OR 1.711, CI 1.117-2.622, p=0.014), respectively. In conclusion, positive statistical association 
between serum cholesterol (total cholesterol, LDL-c and HDL-c) and chloride levels may suggest 
their similar modulation by AHF pathophysiology. Serum levels of total cholesterol, LDL-c and 
chloride contribute to patient survival.
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Introduction
Heart failure (HF) has been in the focus of interest 
of cardiovascular studies because of its high prevalence, 
wide spectrum of etiology and incomplete under-
standing of this syndrome. Due to unclear pathophys-
iology, researchers have directed their attention to dis-
covering the underlying mechanism of HF. Studies 
have been focused mainly on detecting predictors of 
poor outcome and thus hypothesizing and creating 
new concepts of the underlying pathophysiology.
The connection between lipids and coronary artery 
disease has been acknowledged1. Nonetheless, the rela-
tionship between lipids and HF is yet to be clarified. 
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Paradoxically, a well-known fact is that low serum lev-
els of total cholesterol, low-density lipoprotein choles-
terol (LDL-c), high-density lipoprotein cholesterol 
(HDL-c) and triglycerides have been associated with 
worse outcomes in HF studies. This phenomenon is 
part of the so-called reverse epidemiology in HF, 
whereby the risk factors of poor clinical outcome and 
mortality in the general population, such as obesity, 
hypercholesterolemia, and high blood pressure, have 
been associated with better survival2-10. As a result of 
those studies, the level of total cholesterol has become 
part of the predictive models for HF survival such as 
the Seattle Heart Failure Model11. Several studies in-
vestigated the connection between serum lipid levels 
with previously established predictors of outcome in 
HF patients, aiming at elucidating the pathophysiol-
ogy of lipids in HF. However, no study so far has 
 explored the association of serum lipid and chloride 
levels.
Hyponatremia is also considered to have a predic-
tive value for survival in HF patients. Nevertheless, 
studies in the past years showed that serum chloride 
levels were independently and inversely associated 
with mortality in HF patients and that chloride could 
predict development of hyponatremia in these pa-
tients, thus making chloride the main electrolyte for 
predicting outcome in HF patients12-14. The patho-
physiology of hypochloremia in HF is still unknown. 
Exploration of the association between serum lipid 
and chloride levels could generate new knowledge 
concerning HF pathophysiology. Therefore, the pres-
ent study investigated the association between serum 
chloride and lipid levels and their impact on survival in 
acute heart failure (AHF) patients.
Patients and Methods
Study design and patients
The study was a prospective, single-centre, observa-
tional research conducted over 16 months and con-
cluded at the beginning of 2015. It included 152 con-
secutive adults hospitalized for AHF through Emer-
gency Department, Sestre milosrdnice University 
Hospital Centre. The study was designed and conduct-
ed in accordance with the principles of the Declaration 
of Helsinki and approved by the hospital Ethics Com-
mittee15. A written informed consent was obtained 
from the patients. Inclusion required patients older 
than 18 years with a primary diagnosis of AHF, which 
was confirmed within 24 hours of admission by N-
terminal pro-brain natriuretic peptide (NT-proBNP) 
values and echocardiography. The patients were cate-
gorized by clinical presentation of HF and ejection 
fraction (EF)16-18.
Data collection
At first encounter in emergency department, so-
ciodemographic status, past medical history, signs and 
symptoms, as well as chest radiography and electrocar-
diography were obtained in each patient. Echocar-
diography was performed on the first day post admis-
sion. Blood samples were obtained from medial cubital 
vein for routine laboratory assays at admission (com-
plete blood count, metabolic and electrolyte panel, 
blood urea nitrogen, creatinine, lipid profile, and NT-
proBNP). Standard serum electrolytes, renal panel and 
serum lipids were tested on Beckman Coulter instru-
ment AU 2700, 2007 (Brea, CA, US) and Architect 
c8000, Abbott 2013 (Chicago, IL, US). Elecsys e411 
(Roche Diagnostics GmbH, Mannheim, Germany) 
measured the level of Nt-proBNP. Admission chlo-
ride, total plasma cholesterol, LDL-c, HDL-c and tri-
glycerides were defined as values obtained on presen-
tation at emergency department. Hypochloremia was 
defined as serum concentration of chloride lower than 
98 mmol/L. Total cholesterol lower than 5 mmol/L 
was considered normal, and so was the value of LDL-c 
lower than 3 mmol/L. HDL-c concentration higher 
than 1.2 mmol/L in women and higher than 1.00 
mmol/L in men was set as normal. Serum concentra-
tion of triglycerides higher than 1.7 mmol/L was a 
high value.
All data were recorded on days 2, 3 and 7 of hospi-
tal stay, and follow up measurements were performed 
at three months.
Statistical analysis
The MedCalc™ v. 15.1 (MedCalc Software, Bel-
gium) software was used for statistical assessment. 
Kolmogorov-Smirnov test determined the distribu-
tion of quantitative data. After determination, non-
parametric or parametric statistical tests were utilized 
as appropriate. The median and interquartile ranges 
were used to display interquartile ranges. Absolute fre-
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quencies were used for categorical variables. Spearman 
correlation coefficients were calculated to assess the 
correlation of serum chloride and lipid levels. Binary 
logistic regression analysis was performed to study the 
impact of chloride, lipids, statin treatment and EF on 
hospital and 3-month mortality. The level of statistical 
significance was set at p<0.05.
Results
A total of 152 patients were included in the study 
conducted during a 16-month period. Most of the pa-
tients had a positive past medical history of hyperten-
sion (89.5%), metabolic syndrome (55.9%) and type 2 
diabetes mellitus (51.7%). Twenty-five (16.5%) pa-
tients had hypochloremia (Cl <98 mmol/L) at admis-
sion. Hospital mortality was 14.5% (n=22) and after 
3-month follow up, mortality was 27.4% (n=40). Pa-
tient general information is shown in Table 1.
As shown in Figure 1, serum chloride levels were 
significantly correlated with serum levels of total cho-
lesterol (Fig. 1A), LDL-c (Fig. 1B) and HDL-c (Fig. 
1C), but not with serum triglyceride levels (Fig. 1D).
Interestingly, in contrast to chloride, serum sodium 
levels correlated significantly with chloride levels but 
not with serum lipid levels (Table 2).
As revealed by binary logistic regression analyses, 
the levels of serum chloride, total cholesterol and 
LDL-c measured on the first day of hospitalization 
Table 1. Baseline characteristics of patients (N=152)
Baseline characteristics






Body mass index (kg/m2) 28.8 (±5.4)
NYHA 2 (n, %) 11 (7.2%)
NYHA 3 (n, %) 83 (54.6%)
NYHA 4 (n, %) 58 (38.2%)
Distribution of acute heart failure 
by time of onset
Worsening of chronic HF, (n, %) 105 (69.1%)
De novo HF (n, %) 47 (30.9%)
Distribution of acute heart failure 
by ejection fractionα
HFrEF (n, %) 83 (57.6%)
HFpEF (n, %) 61 (42.4%)
EF (%)* 45 (35- 55)
Outcome of hospitalization
Improvement (n, %) 130 (85.5%)
Death at ICU (n, %) 12 (7.9%)
Death on ward (n, %) 10 (6.6%)
Non-survivors after 3 months (n, %) 40 (26.4%)
Vital signs initially
Systolic blood pressure (mm Hg) 140 (120/160)
Diastolic blood pressure (mm Hg) 80 (80- 100)
Heart rate 100 (80-120)
Respiratory rate (n/min) 28 (21-32)
Daily diuresis (mL) 2000 (2700-1300)
Biochemical laboratory parameters
Sodium (mmol/L) 140 (138-143)
Chloride (mmol/L) 104 (100-106)
Creatinine (μmol/L) 106 (87-138)




Nt-proBNP (pg/mL)β 9.5 (3.6-17.4)
Triglycerides (mmol/L) 1.23±0.6
Total cholesterol (mmol/L) 4.14±1.31
HDL-c (mmol/L) 1.02±0.40
LDL-c (mmol/L) 2.6±1.1
Patients with hypochloremia  
(Cl <98 mmol/L) 25 (16.4%)
HFpEF = heart failure with preserved ejection fraction; HFrEF = 
heart failure with reduced ejection fraction; ICU = intensive care 
unit; NYHA = New York Heart Association functional classifica-
tion; Nt-proBNP(pg/mL) = N-terminal pro-brain natriuretic pep-
tide; EF = ejection fraction; LDL-c = low-density lipoprotein 
 cholesterol; HDL-c = high-density lipoprotein cholesterol; α144 
patients included; β147 patients included
Table 2. Correlation of serum sodium and chloride levels 
with serum lipid levels at admission
Variable Sodium (mmol/L)
Chloride (mmol/L) ρ 0.743
p <0.001
Total cholesterol (mmol/L) ρ 0.071
p 0.387
LDL-c (mmol/L) ρ 0.019
p 0.819
HDL-c (mmol/L) ρ 0.106
p 0.195
Triglycerides (mmol/L) ρ 0.057
p 0.489
Spearman’s coefficient of rank correlation was used in calculation; 
LDL-c = low-density lipoprotein cholesterol; HDL-c = high-den-
sity lipoprotein cholesterol; ρ = correlation coefficient; p = calcu-
lated probability
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showed a significant positive association with both 
hospital and 3-month survival of AHF patients (Table 
3). No association was found for serum HDL-c and 
triglycerides (Table 3), or for statin therapy before hos-
pitalization and EF (not shown).
Multiple logistic regression models were made 
with serum sodium, chloride and cholesterol levels, 
therapy and outcome. Although they were significant 
and explained more than 60% of variance, only the as-
sociation of total cholesterol and in-hospital survival 
remained significant (Table 4).
Discussion
In the present study, we found a statistical positive 
correlation between serum cholesterol and chloride 
concentrations. Additionally, we found that patients 
with higher serum cholesterol levels had higher both 
hospital and 3-month survival. Similar was found for 
serum chloride levels, namely, patients with higher se-
rum chloride levels had higher both hospital and 3- 
month survival. Numerous studies in the last ten years 
revealed higher mortality in HF patients with lower 
total cholesterol levels6-8. In contrast, only few studies 
acknowledged low serum chloride levels as a predictor 
of poor outcome in HF patients12-14. To our knowl-
edge, no study so far has addressed the association of 
serum chloride and cholesterol levels in AHF. The re-
lationship between serum chloride and cholesterol 
concentrations in AHF might suggest a similar mode 
of their regulation by AHF pathophysiology. This new 
knowledge might help getting better insight into the 
Fig. 1. Correlation of serum chloride with various lipid levels.
Correlation of serum chloride and (A) total cholesterol; (B) LDL-c; (C) HDL-c; and (D) triglyceride levels was calculated using 
Spearman’s correlation coefficients; ρ = correlation coefficient; LDL-c = low-density lipoprotein cholesterol; HDL-c = high-den-
sity lipoprotein cholesterol
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pathophysiological mechanisms that determine the 
outcome in AHF.
There are several theories regarding the connection 
of low serum lipid levels and poor outcome in HF. Ac-
cording to one of these theories, low cholesterol levels 
are associated with a decreased ability of serum to cope 
with endotoxins, resulting in an increased inflamma-
tory response in HF patients19. There are also several 
theories trying to explain low lipid levels in HF. The 
majority of these theories are based on the assumption 
that decreased calorie intake and impaired intestinal 
nutrient absorption might cause low lipid levels in a 
state of increased resting energy consumption20-22. 
Some recent studies implicated venous congestion and 
thereby associated reduced overall intestinal absorp-
tion, including that of dietary lipids, being an underly-
ing mechanism for low serum lipid levels in HF23. In-
deed, an inverse relationship between serum lipid lev-
els and right ventricle end diastolic diameter (an indi-
cator of the chronic volume overload status in HF) 
argues for the role of venous congestion in lowering 
serum lipids in HF23. However, it is unclear why serum 
chloride and not serum sodium levels are associated 
with serum cholesterol levels, knowing that the intake 
of both sodium and chloride is equally affected in 
bowel edema.
The positive statistical correlation between serum 
cholesterol and chloride levels found in the present 
study suggests that there might be similar pathophysi-
ological mechanisms that modulate their levels in 
AHF. Accordingly, decreased total cholesterol, LDL-c 
and HDL-c levels might be governed by the mecha-
nisms implicated in the pathophysiology of chloride 
disorders in HF. It has been established that WNK 
signaling is involved in chloride sensing, regulation of 
renin-angiotensin-aldosterone system, sodium trans-
port, hypertension and regulation of diuretic activi-
ty24-27. Given the critical role of chloride in a number of 
important regulatory systems, one cannot exclude its 
role in the regulation of cholesterol homeostasis in 
AHF. Further investigation in a greater number of pa-
tients would be interesting28.
Study strengths and limitations
The study had a uniform and structured algorithm 
and protocol for hospitalized AHF patients and ex-
tensive data collection with pre-planned goals. The 
study topic is new, as it has never been considered or 
Table 3. Binary logistic regression analysis of laboratory parameters, and in-hospital and 3-month survival
Variable
In-hospital survival 3-month follow up survival
OR 95% CI p value OR 95% CI p valuelower upper lower upper
Chloride (mmol/L) 1.077 1.010 1.154 0.034 1.065 1.002 1.131 0.042
Total cholesterol (mmol/L) 1.731 1.090 2.748 0.020 1.625 1.147 2.303 0.006
LDL-c (mmol/L) 1.839 1.033 3.274 0.038 1.711 1.117 2.622 0.014
HDL-c (mmol/L) 2.563 0.596 11.022 0.206 2.410 0.775 7.491 0.129
Triglycerides (mmol/L) 1.830 0.682 4.914 0.230 1.658 0.809 3.398 0.167
OR = odds ratio; CI = confidence interval; LDL-c = low-density lipoprotein cholesterol; HDL-c = high-density lipoprotein cholesterol; 
significant associations depicted in bold
Table 4. Multivariate logistic regression analysis of in-hospital and 3-month survival according to serum chloride  
and total cholesterol levels
Variable
In-hospital survival 3-month follow up survival
OR 95% CI p Events OR 95% CI p Eventslower upper lower upper
Chloride (mmol/L) 1.046 0.928 1.179 0.459 22/152 1.016 0.919 1.123 0.508 57/145Total cholesterol (mmol/L) 1.680 1.020 2.770 0.041 1.400 0.957 2.049 0.742
The model was adjusted for age, serum sodium and statin therapy; CI = confidence interval; Events = number of events/number of patients; 
OR = odds ratio
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investigated. Nevertheless, the number of patients en-
rolled in the study was small. The study could not es-
tablish whether low cholesterol or low chloride was 
the cause or merely marker of AHF pathophysiology.
Conclusion
Positive statistical association between serum cho-
lesterol (total cholesterol, LDL-c and HDL-c) and 
chloride levels might suggest their similar modulation 
by AHF pathophysiology. Serum levels of total choles-
terol, LDL-c and chloride contribute to survival in 
AHF patients. Further larger studies are needed to 
confirm and elaborate our findings.
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Sažetak
KOLESTEROL I KLORIDI U AKUTNOM ZATAJIVANJU SRCA
B. Radulović, I. Potočnjak, S. Dokoza Terešak, M. Trbušić, N. Vrkić, A. Huršidić Radulović, N. Starčević,  
M. Milošević, V. Degoricija i S. Frank
Otkrivanje pokazatelja lošijeg ishoda u bolesnika s akutnim zatajivanjem srca je od velike važnosti za razumijevanje nje-
gove patofiziologije, a time i za otkrivanje novih terapijskih pristupa. Poznato je da su niske koncentracije lipida u serumu 
povezane s lošijim ishodom u bolesnika s akutnim zatajivanjem srca. Brojne studije su pokušale utvrditi vezu između kon-
centracije lipida u serumu i ostalih prediktora lošijeg ishoda u bolesnika s akutnim zatajivanjem srca. Cilj istraživanja bio je 
istražiti povezanost koncentracije lipida i klorida u serumu kod bolesnika sa zatajivanjem srca te njihov utjecaj na preživljenje. 
Studija je provedena u obliku prospektivnog opservacijskog istraživanja u jednom bolničkom centru. U istraživanje je bilo 
uključeno 157 bolesnika s akutnim zatajivanjem srca. Spearmanovi koeficijenti korelacije su pokazali značajnu pozitivnu 
povezanost koncentracije klorida i ukupnog kolesterola (ρ 0,221, p=0,006), lipoproteina male gustoće (LDL-c) (ρ 0,187, 
p=0,015) i lipoproteina velike gustoće (HDL-c) (ρ 0,169, p=0,038). Binarnom logističkom regresijom je uočena statistički 
značajna povezanost koncentracije klorida, ukupnog kolesterola i LDL-c u bolesnika s akutnim zatajivanjem srca prilikom 
prijma bolesnika u bolnicu i unutarbolničkog preživljenja (OR 1,077, CI 1,01-1,154, p=0,034), (OR 1,731, CI 1,090-2,748, 
p=0,020) i (OR 1,839, CI 1,033-3,274, p=0,038), kao i preživljenja nakon tri mjeseca (OR 1,065, CI 1,002-1,131, p=0,042), 
(OR 1,625, CI 1,147-2,303, p=0,006) i (OR 1,711, CI 1,117-2,622, p=0,014). Zaključno, pozitivna statistička povezanost 
između koncentracije kolesterola u serumu (ukupni kolesterol, LDL-c i HDL-c) i koncentracije klorida može ukazivati na 
njihovu sličnu ulogu u patofiziologiji akutnog zatajivanja srca. Koncentracija ukupnog kolesterola, LDL-c i klorida u serumu 
sudjeluju u preživljenju bolesnika.
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